Company Epigenomics AG Deutsche Boerse AG
Equities
ECX
DE000A11QW50
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 EUR | -1.92% | +9.51% | -4.03% |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
In Vitro Diagnostic - Products
95.9
%
| 0 | 7.5 % | 0 | 95.9 % | -.--% |
Licensing
4.1
%
| 0 | 0.4 % | 0 | 4.1 % | -9.09% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
54.2
%
| 0 | 4.8 % | 0 | 54.2 % | -11.45% |
Europe
38.6
%
| 0 | 3.0 % | 0 | 38.6 % | -1.06% |
Asia
7.2
%
| 6 | 92.2 % | 0 | 7.2 % | -99.39% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 875,150 | 584,339 ( 66.77 %) | 0 | 66.77 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.13% | 11.53B | |
+45.76% | 3.31B | |
-35.86% | 2.11B | |
-18.27% | 2.05B | |
-27.92% | 1.49B | |
+18.02% | 1.02B | |
-3.49% | 741M | |
-31.42% | 426M | |
+26.64% | 372M |
- Stock Market
- Equities
- ECX Stock
- ECX Stock
- Company Epigenomics AG